[Federal Register Volume 60, Number 196 (Wednesday, October 11, 1995)]
[Notices]
[Pages 52919-52920]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-25084]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Notice of Meeting
Notice if hereby given of the meeting of the NIH AIDS Research
Program Evaluation Working Group Area Review Panel on Behavioral,
Social Science, and Prevention Research on November 2, 1995 from 8:30
a.m. to 5 p.m. at the Omni Shoreham Hotel, 2500 Calvert Street, NW.,
Washington, DC. The meeting will be open to the public from 10 a.m. to
12:30 p.m., and the closed portion will be from 8:30 a.m. to 10 a.m.,
and 1:30 p.m. to 5 p.m.
The NIH Revitalization Act of 1993 authorizes the Office of AIDS
Research (OAR) to evaluate the AIDS research activities of NIH. The NIH
AIDS Research Program Evaluation Working Group was established by the
OAR to carry out this major evaluation initiative, reviewing and
assessing each of the components of the NIH AIDS research endeavor to
determine whether those components are appropriately designed and
coordinated to answer the critical scientific questions to lead to
better treatments, preventions, and a cure for AIDS. Six Area Review
Panels were also established to address the following research areas:
Natural History and Epidemiology; Etiology and Pathogenesis; Clinical
Trials; Drug Discovery; Vaccines; and Behavioral and Social Sciences
Research.
The purpose of the meeting is to seek input from individuals and
organizations interested in the evaluation of AIDS research in the
areas of behavioral, social science, and prevention research. Examples
of areas under consideration by the panel include neuropsychological,
[[Page 52920]]
psychological, social and cultural determinants of risky sexual and
substance use behavior; neuropsychiatric and psychosocial consequences
of HIV infection, including stress, coping, caregiving, and social
stigma, research methodologies employed in AIDS behavioral research,
including quantitative techniques for developing and evaluating
preventive interventions; and the utility of AIDS behavioral
intervention research to affected communities. The NIH AIDS Research
Program Evaluation Working Group will develop recommendations to be
made to the Office of AIDS Research Advisory Council that address the
overall NIH AIDS research initiatives, both intramural and extramural,
and identify long-range goals in the relevant areas of science. These
recommendations will provide the framework for future planning and
budget development of the NIH AIDS research program.
There will be a closed session from 8:30 a.m. to 10 a.m., and 1:30
p.m. to 5 p.m. to update the Panel members on privileged information on
institute and center grant and contract portfolios.
The open session from 10 a.m. to 12:30 p.m. will begin with a brief
overview of panel activities by members of the panel. The remainder of
the meeting will be devoted to presentations from individuals and
organizations. The session is open to the public; however, attendance
may be limited by seat availability.
Comments should be confined to statements related to the current
status of NIH AIDS research in the areas of primary prevention and
behavioral interventions and recommendations for consideration by the
panel in assessing and reviewing the relevant research in these areas.
Only one representative of an organization may present oral
comments. Each speaker will be permitted 5 minutes for their
presentation. Interested individuals and representatives of
organizations must submit a letter of intent to present comments and
three (3) typewritten copies of the presentation, along with a brief
description of the organization represented, to the attention of Dr.
Judith D. Auerbach, Office of AIDS Research, NIH, 231 Center Drive, MSC
2340, Building 31, Room 4C06, Bethesda, MD 20892-2340, (301) 402-3555,
FAX: (301) 402-8638. Letters of intent an copies of presentations must
be received no later than 5 p.m. EDT on Monday, October 23.
Any person attending the meeting who does not request an
opportunity to speak in advance of the meeting will be allowed to make
a brief oral presentation at the conclusion of the meeting, if time
permits, and at the discretion of the Chairperson.
Individuals wishing to provide only written statements should send
three (3) typewritten copies of their comments, including a brief
description of their organization, to the above address no late than 4
p.m. EDT on October 23. Statements submitted after that date will be
accepted. They may not, however, be made available to the Area Review
Panel prior to the meeting, though they will be provide subsequently as
written testimony.
Individuals who plan to attend and need special assistance, such as
sign language interpretation or other accommodations, should contact
Dr. Auerbach in advance of the meeting.
Dated: October 3, 1995.
Susan K. Feldman,
Committee Management Officer, NIH.
[FR Doc. 95-25084 Filed 10-10-95; 8:45 am]
BILLING CODE 4140-01-M
